Generally speaking, those across baseball view Tyler Glasnow as a very talented player.

There’s always one caveat attached to his name, though: If healthy. The fact of the matter is, Glasnow has only thrown 120 innings pitched in one season — and that came this past year for the Rays.

A multitude of arm injuries has derailed his career to an extent. After receiving somewhat of a ‘new age’ Tommy John surgery in 2021, he reportedly feels better than he did before. This includes warming up and pitching without a ton of pain.

Based on the extension L.A. gave him, Glasnow is expected to perform like a front-of-the-rotation arm. On MLB Tonight, former MLB pitcher/three-time All-Star Dan Plesac spoke about Glasnow and his future with the Dodgers.

While effusive in his praise of the Southern California native, he did admit having some apprehension over the deal — calling it a “bigger risk” than the $700 million the Dodgers will pay Shohei Ohtani.

Similarly, long-time ex-MLB executive Dan O’Dowd echoed the sentiments offered by Plesac.

One area of concern O’Dowd brought up generally was the health of starting pitchers within the Dodgers organization.